Literature DB >> 18034679

Field validation of experimental challenge models for IPN vaccines.

A Ramstad1, A B Romstad, D H Knappskog, P J Midtlyng.   

Abstract

Atlantic salmon S1/2 pre-smolts from the VESO Vikan hatchery were assigned to study groups, i.p. immunized with commercially available, multivalent oil-adjuvanted vaccines with (Norvax Compact 6 - NC-6) or without (Norvax Compact 4 - NC-4) recombinant infectious pancreatic necrosis virus (IPNV) antigen. A control group received saline solution. When ready for sea, the fish were transported to the VESO Vikan experimental laboratory, where two identical tanks were stocked with 75 fish per group before being transferred to 10 degrees C sea water and exposed by bath to first passage IPNV grown in CHSE-214 cells. The third tank containing 40 fish from each group was challenged by the introduction of 116 fish that had received an i.p injection of IPNV-challenge material. The remaining vaccinated fish were transported to the VESO Vikan marine field trial site and placed in two identical pens, each containing approximately 53 000 fish from the NC-6 group and 9000 fish from the NC-4 group. In the experimental bath challenge trial, the cumulative mortality was 75% and 78% in the control groups, and the relative percentage survival (RPS) of the NC-6-immunized fish vs. the reference vaccine groups was 60% and 82%, respectively. In the cohabitation challenge, the control mortality reached 74% and the IPNV-specific vaccine RPS was 72%. In both models, the reference vaccine lacking IPNV antigen gave a moderate but statistically significant non-specific protection. In the field, a natural outbreak of infectious pancreatic necrosis (IPN) occurred after 7 weeks lasting for approximately 3.5 months before problems due to winter ulcers became dominating. During this outbreak, mortality in the NC-4 groups were 33.5% and 31.6%, respectively, whereas mortality in the NC-6 groups were 6.9% and 5.3%, respectively, amounting to 81% IPNV-specific protection. In conclusion, the IPN protection estimates obtained by experimental challenges were consistent between tanks, and were confirmed by the field results.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18034679     DOI: 10.1111/j.1365-2761.2007.00858.x

Source DB:  PubMed          Journal:  J Fish Dis        ISSN: 0140-7775            Impact factor:   2.767


  5 in total

Review 1.  Mortality and fish welfare.

Authors:  Tim Ellis; Iain Berrill; Jeff Lines; James F Turnbull; Toby G Knowles
Journal:  Fish Physiol Biochem       Date:  2011-09-16       Impact factor: 2.794

2.  Confirmation and fine-mapping of a major QTL for resistance to infectious pancreatic necrosis in Atlantic salmon (Salmo salar): population-level associations between markers and trait.

Authors:  Thomas Moen; Matthew Baranski; Anna K Sonesson; Sissel Kjøglum
Journal:  BMC Genomics       Date:  2009-08-07       Impact factor: 3.969

Review 3.  Viruses of fish: an overview of significant pathogens.

Authors:  Mark Crane; Alex Hyatt
Journal:  Viruses       Date:  2011-10-25       Impact factor: 5.048

4.  A polyprotein-expressing salmonid alphavirus replicon induces modest protection in atlantic salmon (Salmo salar) against infectious pancreatic necrosis.

Authors:  Azila Abdullah; Christel M Olsen; Kjartan Hodneland; Espen Rimstad
Journal:  Viruses       Date:  2015-01-19       Impact factor: 5.048

5.  A Systematic Approach towards Optimizing a Cohabitation Challenge Model for Infectious Pancreatic Necrosis Virus in Atlantic Salmon (Salmo salar L.).

Authors:  Hetron Mweemba Munang'andu; Nina Santi; Børge Nilsen Fredriksen; Knut-Egil Løkling; Øystein Evensen
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.